Loading clinical trials...
Loading clinical trials...
Persistence of Antibodies After Vaccination With GSK Biologicals' Meningococcal Vaccine GSK134612 in Adolescents and Young Adults
Conditions
Interventions
Blood Sampling
Locations
5
India
GSK Investigational Site
Goa, India
GSK Investigational Site
Indore, India
GSK Investigational Site
New Delhi, India
GSK Investigational Site
Pune, India
GSK Investigational Site
City of Muntinlupa, Philippines
Start Date
September 1, 2009
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
April 12, 2017
NCT04886154
NCT01962207
NCT00508261
NCT01755689
NCT00126984
NCT00196963
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions